Literature DB >> 19936701

Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

A Gautier1, B Balkau, C Lange, J Tichet, F Bonnet.   

Abstract

AIMS/HYPOTHESIS: Risk factors for incident type 2 diabetes, in particular, hepatic markers, have rarely been studied in leaner individuals. We aimed to identify the metabolic and hepatic markers associated with incident diabetes in men and women with a BMI of <27 kg/m(2) and to compare them with those in individuals with a BMI of >or=27 kg/m(2).
METHODS: Risk factors for 9 year incident diabetes were compared in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Comparisons were made between the 2,947 participants with a BMI of <27 kg/m(2) and the 879 with a BMI of >or=27 kg/m(2).
RESULTS: There were 92 incident cases of diabetes in individuals with a BMI of <27 kg/m(2) and 111 in those with a BMI of >or=27 kg/m(2). Among those who were not markedly overweight, classical biological markers were associated with 9 year incident diabetes, glycaemia being the strongest predictor. gamma-Glutamyltransferase (GGT), either considered as a continuous variable or at levels >or=20 U/l, was associated with incident diabetes, with a stronger effect in the BMI <27 kg/m(2) group: OR 1.59 (95% CI 1.29-1.97, p < 0.001) in comparison with OR 1.07 (95% CI 0.82-1.38, p = 0.63) for those with a BMI of >or=27 kg/m(2) (results after adjustment for alcohol intake, alanine aminotransferase, waist circumference and the HOMA insulin resistance index). CONCLUSIONS/
INTERPRETATION: In individuals with a BMI of <27 kg/m(2), GGT was the strongest predictor of diabetes after fasting hyperglycaemia. This association with incident diabetes remained after adjustment for conventional markers of insulin resistance, suggesting potential interactions between GGT, enhanced hepatic neoglucogenesis and/or early alterations of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936701     DOI: 10.1007/s00125-009-1602-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Authors:  Sasiwarang Goya Wannamethee; Andrew Gerald Shaper; Lucy Lennon; Peter H Whincup
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

2.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

Authors:  Barbora Vozarova; Norbert Stefan; Robert S Lindsay; Aramesh Saremi; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

3.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

Authors:  P André; B Balkau; C Born; M A Charles; E Eschwège
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

4.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.

Authors:  Duk Hee Lee; Karri Silventoinen; David R Jacobs; Pekka Jousilahti; Jaakko Tuomileto
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.

Authors:  A F G Cicero; A Dormi; S Nascetti; M P Panourgia; E Grandi; S D'Addato; A Gaddi
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

Review 7.  Is serum gamma glutamyltransferase a marker of oxidative stress?

Authors:  Duk-Hee Lee; Rune Blomhoff; David R Jacobs
Journal:  Free Radic Res       Date:  2004-06

8.  Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.

Authors:  Tara M Wallace; Kristina M Utzschneider; Jenny Tong; Darcy B Carr; Sakeneh Zraika; Daniel D Bankson; Robert H Knopp; Steven E Kahn
Journal:  Diabetes Care       Date:  2007-07-31       Impact factor: 19.112

9.  Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

Authors:  Noriyuki Nakanishi; Kenji Suzuki; Kozo Tatara
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

10.  Oxidative stress and insulin resistance: the coronary artery risk development in young adults study.

Authors:  Kyong Park; Myron Gross; Duk-Hee Lee; Paul Holvoet; John H Himes; James M Shikany; David R Jacobs
Journal:  Diabetes Care       Date:  2009-04-23       Impact factor: 17.152

View more
  10 in total

1.  Review of current clinical biomarkers for the detection of alcohol dependence.

Authors:  Hamid R Tavakoli; Michael Hull; Lt Michael Okasinski
Journal:  Innov Clin Neurosci       Date:  2011-03

2.  Increased liver markers are associated with higher risk of type 2 diabetes.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Kyung-Do Han; Seung-Hyun Ko; Yu-Bae Ahn
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Authors:  Gábor Firneisz; Tímea Varga; Gabriella Lengyel; János Fehér; Dóra Ghyczy; Barna Wichmann; László Selmeci; Zsolt Tulassay; Károly Rácz; Anikó Somogyi
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

4.  Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA).

Authors:  Luis A Rodriguez; Alka M Kanaya; Stephen C Shiboski; Alicia Fernandez; David Herrington; Jingzhong Ding; Patrick T Bradshaw
Journal:  Ann Epidemiol       Date:  2021-07-19       Impact factor: 3.797

5.  Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.

Authors:  Fabrice Bonnet; Pierre-Henri Ducluzeau; Amalia Gastaldelli; Martine Laville; Christian H Anderwald; Thomas Konrad; Andrea Mari; Beverley Balkau
Journal:  Diabetes       Date:  2011-04-26       Impact factor: 9.461

6.  Low water intake and risk for new-onset hyperglycemia.

Authors:  Ronan Roussel; Léopold Fezeu; Nadine Bouby; Beverley Balkau; Olivier Lantieri; François Alhenc-Gelas; Michel Marre; Lise Bankir
Journal:  Diabetes Care       Date:  2011-10-12       Impact factor: 19.112

7.  Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men.

Authors:  In Ho Seo; Hyung Bin Lee; Shinhye Kim; Yong Jae Lee; Dong Hyuk Jung
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

8.  Association of liver enzymes levels with fasting plasma glucose levels in Southern China: a cross-sectional study.

Authors:  Ling-Ling Huang; Dong-Hui Guo; Hui-Yan Xu; Song-Tao Tang; Xiao Xiao Wang; Yong-Ping Jin; Peixi Wang
Journal:  BMJ Open       Date:  2019-10-18       Impact factor: 2.692

9.  Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.

Authors:  Pedro Marques-Vidal; Rémy Schmid; Murielle Bochud; François Bastardot; Roland von Känel; Fred Paccaud; Jennifer Glaus; Martin Preisig; Gérard Waeber; Peter Vollenweider
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

Review 10.  Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk.

Authors:  Gerald Koenig; Stephanie Seneff
Journal:  Dis Markers       Date:  2015-10-12       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.